2-Amino-5-methylpyridine
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
1603-41-4Cc1ccc(N)nc1CMBSSVKZOPZBKW-UHFFFAOYSA-Nstructure in first source
1603-41-4DTXSID4029220CHEMBL61990Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (98.3%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 60 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Status: Active Update: 15-10-2019 https://echa.europa.eu/registration-dossier/-/registered-dossier/20106
2-Amino-5-methylpyridine: Does not have an individual approval but may be used under an appropriate group standard
Verwenden2-Amino-5-methylpyridine is used as an intermediate in the pharmaceutical industry for the manufacture of Avosentan (used in diabetic nephropathy), Pirfenidone (anti-inflammatory, anti-oxidant and antifibrotic agent) and Zolpidem (sedative/ hypnotics). It is also used for the manufacture of Fluazuron, which is a pesticide, and for commercial purposes.
Wird geladen…